Affiliated with a Castle Connolly Top Hospital
Who is Dr. Miklos, Hematologist in Stanford, CA?
Dr. David Miklos, MD is a Hematologist, who primarily practices in Stanford, CA with 1 additional practice location. Dr. Miklos graduated from Yale University School of Medicine and completed his residency at Brigham and Women's Hospital Harvard Medical School. Dr. Miklos is fluent in English, and is currently seeing new patients. Dr. Miklos’s practice accepts Kaiser Permanente, Medicaid, Medicare and other major insurance plans. To book an appointment or to confirm insurance options, please call Dr. Miklos’s office at (650) 723-4000.
Where did Dr. Miklos go to medical school and complete their residency?
Fellowship: Dana Farber Cancer Institute
Residency: Brigham and Women's Hospital Harvard Medical School | Brigham & Women's Hospital Program
Medical School: Yale University School of Medicine
What languages does Dr. Miklos speak?
Dr. Miklos and their clinical team can communicate with patients in the following languages:
English
What conditions does a Hematologist like Dr. Miklos typically treat?
As a Hematologist, Dr. Miklos diagnoses, treats, and manages a wide range of conditions. This condition information is derived from anonymized insurance claims and highlights the medical conditions most commonly treated by Dr. Miklos. It provides insight into the doctor’s areas of experience and expertise based on real-world patient encounters from the past two years, updated quarterly. Learn more about our claims-based healthcare methodology here.
Also known as:
- Diffuse Large B-cell Lymphoma
- Lymphoma
- DLBCL
- Large B-cell Lymphoma
- Aggressive B-cell Lymphoma
- Diffuse B-cell Lymphoma
ICD-10 Codes:
- C8333: Diffuse large B-cell lymphoma, intra-abdominal lymph nodes
- C8330: Diffuse large B-cell lymphoma, unspecified site
- C8338: Diffuse large B-cell lymphoma, lymph nodes of multiple sites
Also known as:
- Multiple Myeloma
- Plasma Cell Neoplasms (Including Multiple Myeloma) Treatment (PDQ®)
- Active multiple myeloma
- Untreated multiple myeloma
- Plasma cell myeloma
ICD-10 Codes:
- C9000: Multiple myeloma not having achieved remission
Also known as:
- Acute Myeloid Leukemia in Remission
- Acute Myeloid Leukemia
- AML Leukemia in Remission
- Acute Myeloblastic Leukemia in Remission
- Acute Myelogenous Leukemia in Remission
ICD-10 Codes:
- C9201: Acute myeloblastic leukemia, in remission
What procedures does a Hematologist like Dr. Miklos typically perform?
As a Hematologist, Dr. Miklos performs a variety of medical procedures. This procedure information is derived from anonymized insurance claims and highlights the medical procedures most commonly performed by Dr. Miklos. It provides insight into the doctor’s areas of experience and expertise based on real-world patient encounters from the past two years, updated quarterly. Learn more about our claims-based healthcare methodology here.
Also known as:
- Bone Marrow Biopsy and Aspiration
- Bone Marrow Aspiration
- Biopsy
- Bone Marrow Tests
- Bone Marrow Exam
- Bone Marrow Sample Collection
- Diagnostic Bone Marrow Procedure
- Bone Marrow Biopsy
- Marrow Aspiration
- Diagnostic Bone Marrow Test
- Bone Marrow Sample
CPT Codes:
- 38222: Diagnostic bone marrow; biopsy(ies) and aspiration(s)
- 38220: Diagnostic bone marrow; aspiration(s)
Also known as:
- Collecting Patient's Own Blood Stem Cells for Transplant
- Autologous Stem Cell Harvest
- Blood Stem Cell Collection
- Hematopoietic Stem Cell Apheresis
CPT Codes:
- 38206: Blood-derived hematopoietic progenitor cell harvesting for transplantation, per collection; autologous
Also known as:
- Stem Cell Freezing and Storage
- Hematopoietic Stem Cell Cryopreservation
- Blood Stem Cell Storage
- Bone Marrow Stem Cell Banking
CPT Codes:
- 38207: Transplant preparation of hematopoietic progenitor cells; cryopreservation and storage
Also known as:
- Removal of Tunneled Central Venous Catheter
- Central Line Removal
- Tunneled Catheter Extraction
- Venous Access Device Removal
CPT Codes:
- 36589: Removal of tunneled central venous catheter, without subcutaneous port or pump
Also known as:
- Blood Transfusion
- Blood Transfusion and Donation
- Blood product transfusion
- Red blood cell transfusion
- Plasma transfusion
CPT Codes:
- 36430: Transfusion, blood or blood components
Also known as:
- PICC Line Insertion (Adult/Older Child)
- Peripherally Inserted Central Catheter
- PICC Line Placement
- Central Venous Catheter Insertion
CPT Codes:
- 36573: Insertion of peripherally inserted central venous catheter (PICC), without subcutaneous port or pump, including all imaging guidance, image documentation, and all associated radiological supervision and interpretation required to perform the insertion; age 5 years or older
Does Dr. Miklos accept my insurance?
Dr. Miklos accepts most major insurance plans. Important: Please call our office at (650) 723-4000 before your appointment to verify that your specific plan and network are accepted.
What insurance plans does Dr. Miklos accept in Stanford, CA?
Dr. Miklos in Stanford, CA accepts plans from many carriers. While this list is updated regularly, it is not a guarantee of coverage.
Top Insurances
All Other Third Party
Blue Shield of California
CVS Health (formerly Aetna)
Kaiser Permanente
Medicaid
Medicare
Santa Cruz County
State of California
UnitedHealth Group
Unknown
View All Insurances
Where is Dr. Miklos' office located?
Recognitions
Publications
A distinct evolution of the T
, 2013
H-Y antigen-binding B cells develop in male recipients of female hematopoietic cells
, 2013
High-throughput VDJ sequencing for quantification of minimal residual disease in chronic
, 2011
Measurement and Clinical Monitoring of Human Lymphocyte Clolity by Massively Parallel V-D
, 2009
Birth Order and Transplantation Outcome in HLA-Identical Sibling Stem Cell Transplantation
, 2013
Clolly identical Hodgkin's disease develops after allogeneic hematopoietic cell transplant for CLL
, 2011
The Outcomes of Family Haploidentical Hematopoietic Stem Cell Transplantation
, 2011
B cells promote insulin resistance through modulation of T cells
, 2011
Long-term outcomes in patients with high
, 2011
Recombint antigen microarrays for serum/plasma antibody detection.
, 2011
Complete donor T-cell engraftment 30 days after allogeneic transplantation predicts molecular
, 2010
Allogeneic T cells impair engraftment and hematopoiesis after stem cell transplantation.
, 2010
Individual Variation in the Germline Ig Gene Repertoire Inferred from Variable Region Gene
, 2010
Identifying compartment-specific non
, 2009
B Cells and Transplantation: An Educatiol Resource
, 2009
Rel pathology in hematopoietic cell transplantation recipients
, 2008
Toward biomarkers for chronic graft-versus-host disease
, 2006
Minimal residual disease quantification using consensus primers
, 2013
A distinct evolution of the T
, 2013
H-Y antigen-binding B cells develop in male recipients of female hematopoietic cells
, 2013
Massive evolution of the immunoglobulin heavy chain locus
, 2012
Prophylactic rituximab after allogeneic transplantation decreases B
, 2012
High-throughput VDJ sequencing for quantification of minimal residual disease in chronic
, 2011
Measurement and Clinical Monitoring of Human Lymphocyte Clonality by Massively Parallel V-D
, 2009
Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft
, 2005
Birth Order and Transplantation Outcome in HLA-Identical Sibling Stem Cell Transplantation
, 2013
Humoral Immunity to Cytomegalovirus and Chronic Graft-Versus-Host Disease
, 2012
Sirolimus and mycophenolate mofetil as GVHD prophylaxis in myeloablative
, 2012
Clonally identical Hodgkin's dise
, 2011
Adoptive Immunotherapy with Cytokine
, 2011
A phase 1 study of imatinib for corticosteroid-dependent
, 2011
Combined CD4 T-Cell
, 2011
The Outcomes of Family Haploidentical Hematopoietic Stem Cell Transplantation
, 2011
B cells promote insulin resistance through modulation of T cells
, 2011
Protein Microarrays Discover Angiotensinogen
, 2011
Long-term outcomes in patients with high
, 2011
Recombinant antigen microarrays for serum/plasma antibody detection.
, 2011
Outcomes of pediatric bone marrow transplantation for leukemia
, 2010
H-Y antibody titers are increased in unexplained secondary recurrent miscarriage patients
, 2010
Complete donor T-cell engraftment 30 days after allogeneic transplantation predicts molecular
, 2010
Allogeneic T cells impair engraftment and hematopoiesis after stem cell transplantation.
, 2010
Phase I/II Trial of GN-BVC
, 2010
Individual Variation in the Germline Ig Gene Repertoire Inferred from Variable Region Gene
, 2010
Rituximab in hematopoietic cell transplantation
, 2010
Antibodies specifically target AML antigen NuSAP1 after allogeneic bone marrow transplantation
, 2010
TLI and ATG conditioning with low risk of graft-versus
, 2009
Identifying compartment-specific non
, 2009
B Cells and Transplantation: An Educational Resource
, 2009
H-Y antibody development associates with acute rejection in female patients with male kidney
, 2008
Renal pathology in hematopoietic cell transplantation recipients
, 2008
Rituximab for steroid-refractory chronic graft-versus-host disease
, 2006
Toward biomarkers for chronic graft-versus-host disease
, 2006
Antibody response to DBY minor histocompatibility antigen is induced after allogeneic stem cell
, 2004
What is Dr. Miklos's NPI number?An National Provider Identifier (NPI) is a unique ID number that identifies doctors and healthcare providers nationwide.
Dr. Miklos's National Provider Identifier (NPI) number is 1982751053.
What common questions do patients ask about Dr. Miklos?
Here are answers to patients Frequently Asked Questions (FAQ’s) about Dr. Miklos
What is Dr. David Miklos's specialty?
Dr. Miklos is a Hematologist near Stanford, CA.
What does a Hematologist do?
An internist with advanced training specializing in disorders of the blood, spleen, and lymphatic system. This specialist manages conditions such as anemia, clotting disorders, sickle cell disease, hemophilia, leukemia, and lymphoma.
Is this Dr. David Miklos affiliated with a ranked Castle Connolly Top Hospital?
Yes, Dr. Miklos is affiliated with Stanford Health Care - Stanford Hospital, Stanford Health Care - Valleycare, Kaiser Permanente Santa Clara Medical Center, Kaiser Permanente South Sacramento Medical Center, Kaiser Permanente Oakland Medical Center which are a Castle Connolly Top Hospitals. Castle Connolly Top Hospitals are healthcare institutions recognized for their excellence in specific medical procedures and overall patient care. They are identified through a rigorous peer nomination process, evaluating factors like patient outcomes, quality of care, and expertise. The list recognizes hospitals that excel in 20 or more specific medical procedures, representing the top 25% nationwide. Castle Connolly Top Hospitals
When to see a Hematologist?: Guides for symptoms, conditions, and treatments
Understand your symptoms and know when it’s time to see a Hematologist. Explore insights from trusted medical experts on EverydayHealth.com, where you'll find the most relevant content and helpful condition guides for up-to date information about symptoms, causes, diagnosis, treatment and more. See all our health guides to find trusted information on medical conditions from our experts at Everyday Health.
Is David Miklos accepting new patients in Stanford, CA?
Yes, Dr. David Miklos is accepting new patients at this time.
Does Dr. David Miklos offer online booking?
Please contact Dr. Miklos's office at (650) 723-4000 for information about online booking, telehealth, or to schedule an appointment.
How can I make an appointment with David Miklos?
Please contact Dr. Miklos's office at (650) 723-4000 for information regarding telehealth appointment availability or for scheduling assistance.
Other Hematologist Near Stanford, CA
Medical Oncologist
Accepting patientsMedical Oncologist
Accepting patientsMedical Oncologist
Accepting patients